![Javier García Cogorro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Javier García Cogorro
Fondateur chez
Columbus Venture Partners SGEIC SA
Profil
Javier García Cogorro is the founder.
At Columbus Venture Partners SGEIC SA, founded in 2015, Mr. García Cogorro serves as General Partner.
Mr. García Cogorro is also the founder of Viralgen Vector Core SL.
Current jobs include Director at The National Alliance For Hispanic Health, Director at Vivet Therapeutics SAS since 2017, and Director at Highlight Therapeutics SL.
Former jobs include Director at AskBio Inc. and Director at Artax Biopharma, Inc. Education includes an undergraduate degree from Universidad Complutense de Madrid, conferred in 1986, and an MBA from Instituto Catolico de Administracion y Direccion de Empresas, conferred in 1990.
Postes actifs de Javier García Cogorro
| Sociétés | Poste | Début |
|---|---|---|
Columbus Venture Partners SGEIC SA
 Columbus Venture Partners SGEIC SA Investment ManagersFinance Columbus VP invests in companies located in Spain. The firm focuses on biotechnology, medical technology, pharmaceutical and healthcare sectors. It provide financing for seed, early and later stage capital requirement. It makes co investments and takes a seat on the broad of directors. | Fondateur | 01/01/2015 |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Directeur/Membre du Conseil | 04/04/2017 |
The National Alliance For Hispanic Health
 The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | - |
Highlight Therapeutics SL
 Highlight Therapeutics SL BiotechnologyHealth Technology Develops immuno-oncology treatments for skin cancers | Directeur/Membre du Conseil | - |
Anciens postes connus de Javier García Cogorro
| Sociétés | Poste | Fin |
|---|---|---|
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Directeur/Membre du Conseil | - |
Viralgen Vector Core SL
 Viralgen Vector Core SL BiotechnologyHealth Technology Engages in research, development, manufacturing and distribution of gene therapy products | Directeur Général | 01/01/2023 |
AskBio Inc.
 AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Directeur/Membre du Conseil | - |
Formation de Javier García Cogorro
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
AskBio Inc.
AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Health Technology |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Health Technology |
Universidad Complutense de Madrid
 Universidad Complutense de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Alliance For Hispanic Health
The National Alliance For Hispanic Health Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Instituto Catolico de Administracion y Direccion de Empresas
 Instituto Catolico de Administracion y Direccion de Empresas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbus Venture Partners SGEIC SA
Columbus Venture Partners SGEIC SA Investment ManagersFinance Columbus VP invests in companies located in Spain. The firm focuses on biotechnology, medical technology, pharmaceutical and healthcare sectors. It provide financing for seed, early and later stage capital requirement. It makes co investments and takes a seat on the broad of directors. | Finance |
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Health Technology |
Highlight Therapeutics SL
Highlight Therapeutics SL BiotechnologyHealth Technology Develops immuno-oncology treatments for skin cancers | Health Technology |
Viralgen Vector Core SL
Viralgen Vector Core SL BiotechnologyHealth Technology Engages in research, development, manufacturing and distribution of gene therapy products | Health Technology |
